BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 18677283)

  • 1. Audiological application criteria for implantable hearing aid devices: a clinical experience at the Nijmegen ORL clinic.
    Verhaegen VJ; Mylanus EA; Cremers CW; Snik AF
    Laryngoscope; 2008 Sep; 118(9):1645-9. PubMed ID: 18677283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vibrant Sound Bridge System. A new kind hearing prosthesis for patients with sensorineural hearing loss. 2. Audiological results].
    Lenarz T; Weber BP; Issing PR; Gnadeberg D; Ambjørnsen K; Mack KF; Winter M
    Laryngorhinootologie; 2001 Jul; 80(7):370-80. PubMed ID: 11488147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Otologics middle ear transducer with contralateral conventional hearing aid in severe sensorineural hearing loss: evolution during the first 24 months.
    Tringali S; Perrot X; Berger P; Granade GL; Dubreuil C; Truy E
    Otol Neurotol; 2010 Jun; 31(4):630-6. PubMed ID: 20418795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advantages of binaural hearing provided through bimodal stimulation via a cochlear implant and a conventional hearing aid: a 6-month comparative study.
    Morera C; Manrique M; Ramos A; Garcia-Ibanez L; Cavalle L; Huarte A; Castillo C; Estrada E
    Acta Otolaryngol; 2005 Jun; 125(6):596-606. PubMed ID: 16076708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vibrant Soundbridge for hearing restoration after chronic ear surgery.
    Streitberger C; Perotti M; Beltrame MA; Giarbini N
    Rev Laryngol Otol Rhinol (Bord); 2009; 130(2):83-8. PubMed ID: 19813469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term assessment after implantation of the Vibrant Soundbridge device.
    Schmuziger N; Schimmann F; àWengen D; Patscheke J; Probst R
    Otol Neurotol; 2006 Feb; 27(2):183-8. PubMed ID: 16436987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U.S. Phase I preliminary results of use of the Otologics MET Fully-Implantable Ossicular Stimulator.
    Jenkins HA; Atkins JS; Horlbeck D; Hoffer ME; Balough B; Arigo JV; Alexiades G; Garvis W
    Otolaryngol Head Neck Surg; 2007 Aug; 137(2):206-12. PubMed ID: 17666242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vibrant soundbridge versus conventional hearing aid in sensorineural high-frequency hearing loss: a prospective study.
    Truy E; Philibert B; Vesson JF; Labassi S; Collet L
    Otol Neurotol; 2008 Aug; 29(5):684-7. PubMed ID: 18434928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of stimulus level on the speech perception abilities of children using cochlear implants or digital hearing aids.
    Davidson LS
    Ear Hear; 2006 Oct; 27(5):493-507. PubMed ID: 16957500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Otologics fully implantable hearing system: Phase I trial 1-year results.
    Jenkins HA; Atkins JS; Horlbeck D; Hoffer ME; Balough B; Alexiades G; Garvis W
    Otol Neurotol; 2008 Jun; 29(4):534-41. PubMed ID: 18317397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active middle ear implantation for patients with sensorineural hearing loss and external otitis: long-term outcome in patient satisfaction.
    Zwartenkot JW; Hashemi J; Cremers CW; Mulder JJ; Snik AF
    Otol Neurotol; 2013 Jul; 34(5):855-61. PubMed ID: 23739560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active middle ear implants in patients undergoing subtotal petrosectomy: new application for the Vibrant Soundbridge device and its implication for lateral cranium base surgery.
    Linder T; Schlegel C; DeMin N; van der Westhuizen S
    Otol Neurotol; 2009 Jan; 30(1):41-7. PubMed ID: 18849883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of the safety and performance of the Otologics fully implantable hearing device: transducing sounds via the round window membrane to the inner ear.
    Lefebvre PP; Martin C; Dubreuil C; Decat M; Yazbeck A; Kasic J; Tringali S
    Audiol Neurootol; 2009; 14(3):172-80. PubMed ID: 19005251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of active middle ear implants in patients with severe mixed hearing loss.
    Verhaegen VJ; Mulder JJ; Cremers CW; Snik AF
    Otol Neurotol; 2012 Apr; 33(3):297-301. PubMed ID: 22366752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active middle ear implant compared with open-fit hearing aid in sloping high-frequency sensorineural hearing loss.
    Boeheim K; Pok SM; Schloegel M; Filzmoser P
    Otol Neurotol; 2010 Apr; 31(3):424-9. PubMed ID: 20042907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Our auditory results using the Vibrant Soundbridge on the long process of the incus: 20 years of data.
    Grégoire A; Van Damme JP; Gilain C; Bihin B; Garin P
    Auris Nasus Larynx; 2018 Feb; 45(1):66-72. PubMed ID: 28285827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrant Soundbridge middle ear implant in mixed hearing loss. Indications, techniques, results.
    Dumon T; Gratacap B; Firmin F; Vincent R; Pialoux R; Casse B; Firmin B
    Rev Laryngol Otol Rhinol (Bord); 2009; 130(2):75-81. PubMed ID: 19813468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fully implantable hearing aids in patients with congenital auricular atresia.
    Siegert R; Mattheis S; Kasic J
    Laryngoscope; 2007 Feb; 117(2):336-40. PubMed ID: 17277630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative ossicular loading with the Otologics fully implantable hearing device.
    Jenkins HA; Pergola N; Kasic J
    Acta Otolaryngol; 2007 Apr; 127(4):360-4. PubMed ID: 17453454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid cochlear implantation: clinical results and critical review in 13 cases.
    Luetje CM; Thedinger BS; Buckler LR; Dawson KL; Lisbona KL
    Otol Neurotol; 2007 Jun; 28(4):473-8. PubMed ID: 17529849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.